In the case of MALAT1, its expression has been shown to be upregulated in some lymphoid neoplasms such as DLBCL10, chronic lymphocytic leukemia (CLL)11, and mantle cell lymphoma (MCL)12. This evidence concerns the gene MALAT1 and mantle cell lymphoma.